BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17237905)

  • 1. Family history is neglected in the work-up of patients with colorectal cancer: a quality assessment using cancer registry data.
    van Dijk DA; Oostindiër MJ; Kloosterman-Boele WM; Krijnen P; Vasen HF;
    Fam Cancer; 2007; 6(1):131-4. PubMed ID: 17237905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Underutilization of microsatellite instability analysis in colorectal cancer patients at high risk for Lynch syndrome.
    Van Lier MG; De Wilt JH; Wagemakers JJ; Dinjens WN; Damhuis RA; Wagner A; Kuipers EJ; Van Leerdam ME
    Scand J Gastroenterol; 2009; 44(5):600-4. PubMed ID: 19153873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Family history? The forgotten question in high-risk colorectal cancer patients.
    Foo W; Young JM; Solomon MJ; Wright CM
    Colorectal Dis; 2009 Jun; 11(5):450-5. PubMed ID: 19508517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [More hereditary intestinal cancer can be detected if patients with colorectal carcinoma that are selected by the pathologist are examined for microsatellite instability].
    de Bruin JH; Kievit W; Ligtenberg MJ; Nagengast FM; Adang EM; Ruers TJ; Kleibeuker JH; Sijmons RH; van Krieken JH; Hoogerbrugge N
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1792-8. PubMed ID: 16121665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic.
    Lipton LR; Johnson V; Cummings C; Fisher S; Risby P; Eftekhar Sadat AT; Cranston T; Izatt L; Sasieni P; Hodgson SV; Thomas HJ; Tomlinson IP
    J Clin Oncol; 2004 Dec; 22(24):4934-43. PubMed ID: 15611508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening.
    Julié C; Trésallet C; Brouquet A; Vallot C; Zimmermann U; Mitry E; Radvanyi F; Rouleau E; Lidereau R; Coulet F; Olschwang S; Frébourg T; Rougier P; Nordlinger B; Laurent-Puig P; Penna C; Boileau C; Franc B; Muti C; Hofmann-Radvanyi H
    Am J Gastroenterol; 2008 Nov; 103(11):2825-35; quiz 2836. PubMed ID: 18759827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: Detection and management of hereditary non-polyposis colorectal cancer (Lynch syndrome).
    Ramsoekh D; Van Leerdam ME; Wagner A; Kuipers EJ
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():101-11. PubMed ID: 18081654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Awareness of heredity in colorectal cancer patients is insufficient among clinicians: a Norwegian population-based study.
    Tranø G; Wasmuth HH; Sjursen W; Hofsli E; Vatten LJ
    Colorectal Dis; 2009 Jun; 11(5):456-61. PubMed ID: 19508550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hereditary predisposition of colorectal cancer and prevalence of hereditary nonpolyposis colorectal cancer in general population of colorectal cancer patients in China].
    Zhang YZ; Sheng JQ; Li SR; Wu ZT
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2995-3000. PubMed ID: 16324388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary nonpolyposis colorectal carcinoma (HNPCC) and HNPCC-like families: Problems in diagnosis, surveillance, and management.
    Lynch HT; Riley BD; Weissman SM; Coronel SM; Kinarsky Y; Lynch JF; Shaw TG; Rubinstein WS
    Cancer; 2004 Jan; 100(1):53-64. PubMed ID: 14692024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic and pedigree differences in amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status.
    Valle L; Perea J; Carbonell P; Fernandez V; Dotor AM; Benitez J; Urioste M
    J Clin Oncol; 2007 Mar; 25(7):781-6. PubMed ID: 17228022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic testing offered directly after the diagnosis of colorectal cancer: a pilot study on the reactions of patients.
    Landsbergen KM; Prins JB; Brunner HG; Hoogerbrugge N
    Genet Couns; 2009; 20(4):317-25. PubMed ID: 20162866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches to identification of HNPCC suspected patients in Slovak population.
    Fridrichová I; Ilencíková D; Friedl W; Hlavcák P; Skorvaga M; Krizan P; Pálaj J; Pirsel M; Farkasová E; Bartosová Z
    Neoplasma; 2000; 47(4):219-26. PubMed ID: 11043825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology.
    Batra S; Valdimarsdottir H; McGovern M; Itzkowitz S; Brown K
    Am J Gastroenterol; 2002 Mar; 97(3):729-33. PubMed ID: 11922570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: The Lynch syndrome (hereditary nonpolyposis colorectal cancer).
    Vasen HF
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():113-26. PubMed ID: 18081655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective assessment of microsatellite instability in gastrointestinal neoplasia in Ashkenazi and non-Ashkenazi Jews.
    Strul H; Liberman E; Kariv R; Gartner M; Kazanov D; Keidar A; Carmeli Y; Degani Y; Halpern Z; Arber N
    J Med; 2003; 34(1-6):139-48. PubMed ID: 17682319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [When and how to investigate a mutation predisposing to the Lynch syndrome].
    Robert-Grandpierre F; Bressoud A; Hutter P; Tschantz P
    Rev Med Suisse Romande; 2001 May; 121(5):357-60. PubMed ID: 11450192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of a new strategy to identify HNPCC patients.
    Kievit W; de Bruin JH; Adang EM; Severens JL; Kleibeuker JH; Sijmons RH; Ruers TJ; Nagengast FM; Vasen HF; van Krieken JH; Ligtenberg MJ; Hoogerbrugge N
    Gut; 2005 Jan; 54(1):97-102. PubMed ID: 15591512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing the detection of hereditary non-polyposis colorectal cancer: an update.
    De Bruin JH; Ligtenberg MJ; Nagengast FM; Adang EM; Van Krieken JH; Hoogerbrugge N
    Scand J Gastroenterol Suppl; 2006; (243):146-52. PubMed ID: 16782634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Who should be sent for genetic testing in hereditary colorectal cancer syndromes?
    Lynch HT; Boland CR; Rodriguez-Bigas MA; Amos C; Lynch JF; Lynch PM
    J Clin Oncol; 2007 Aug; 25(23):3534-42. PubMed ID: 17687158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.